Cargando…

Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Therapy in the Management of Latent Autoimmune Diabetes in Adults (LADA): A Systematic Review and Meta Analysis

Objective: Latent autoimmune diabetes in adults (LADA) has been shown in recent studies to have heterogeneous pathophysiology and phenotype. Although insulin is considered as the therapeutic choice for these patients, other antidiabetic drugs have been studied in terms of glycemic control and beta c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alanes Escueta, Luz Margaret, Jasul, Gabriel Villaflor, Dampil, Oliver Allan Castillo, Laforteza, Alexis Roberto Yamane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090552/ http://dx.doi.org/10.1210/jendso/bvab048.935

Ejemplares similares

SUN-124 Latent Autoimmune Diabetes of the Adult (LADA): Is It Gestational Diabetes?
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019)

SUN-159 Evaluation of Underestimating the Diagnosis of LADA in a Population in the Southeastern Region of Brazil
por: da Silva, Debora, et al.
Publicado: (2019)

THU358 A Case Of Latent Autoimmune Diabetes In Adults (LADA) Managed By Lifestyle And Dietary Intervention Alone
por: Waseem Ahmad, Malik, et al.
Publicado: (2023)

Is DPP-4 Use Associated With a Decreased Mortality for COVID-19 Diabetic Patients? A Meta-Analysis
por: Sun, Chenyu, et al.
Publicado: (2021)

A Case of Euglycemic Diabetic Ketoacidosis (DKA), Influenza, and a Dipeptidyl Peptidase-4 (DPP-4) Inhibitor
por: Jeong, Su Hyun, et al.
Publicado: (2023)

SAT-LB031 Empagliflozin as an Add-On Medication to Subjects Uncontrolled on DPP4 Inhibitors and Metformin: Real World Data Supporting the Use of Empagliflozin as a Rational Second Add-On in Indian Type 2 Diabetic Patients
por: MS, ANEESH
Publicado: (2019)

SUN-LB122 Sequential Testing to Assess Insulin Resistance in the Course of Participation in a Diabetes Prevention Program (DPP)
por: McPhaul, Michael John, et al.
Publicado: (2020)

MON-653 The Effects of DPP IV Inhibitor on Glycemic Variability in Type 2 Diabetic Patients Treated with Twice Daily Premixed Human Insulin
por: Tan, Florence Hui Sieng, et al.
Publicado: (2020)

An Atypical Case of Latent Autoimmune Diabetes of Adults
por: Kim, Keun Young, et al.
Publicado: (2021)

FRI633 Financial Benefits Of Renal Dose-adjusted Dipeptidyl Peptidase-4 Inhibitors For Patients With Type 2 Diabetes And Chronic Kidney Disease: A Multicenter Study Utilizing Common Data Model
por: Jee Choe, Hun, et al.
Publicado: (2023)

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin
por: Hee, Nicholas Ken Yoong, et al.
Publicado: (2022)

Approach to Diagnosis and Management Latent Autoimmune Diabetes in Adults: A Case Report
por: Gemiana, Dita, et al.
Publicado: (2021)

SUN-122 Latent Autoimmune Diabetes in Adults Presenting in a Geriatric Patient with Autoimmune Hypothyroidism
por: Guzman, Heidi, et al.
Publicado: (2019)

SAT-164 Cornus Officinalis Significantly Improves Oxidative Capacity and Promotes the Calcium-Dependent Transcription Factor, NFATC2, in Human 1.1B4 Pancreatic Cell Line
por: Sharp, Arielle, et al.
Publicado: (2019)

An Unusual Case of Latent Autoimmune Diabetes in Adult and Pancreatic Neuroendocrine Tumor in a Patient Presenting With Diabetes
por: Baral, Neelam, et al.
Publicado: (2021)

SUN-123 An Unusual Case of How Statin-Induced Diabetes Revealed Underlying Latent Autoimmune Diabetes of Adulthood
por: Mai, Raymond, et al.
Publicado: (2019)

OR22-4 Recurrent Hypoglycemia, Fragmentation of Care, and Mortality in Chicago
por: O'Connor, Clare, et al.
Publicado: (2019)

OR31-4 Neonatal Vitamin D Deficiency and Insulin Resistance
por: McNerney, Kyle, et al.
Publicado: (2019)

SAT-183 Activating Transcription Factor 4 (ATF4) As A Possible Mediator Of Gluconeogenic And Lipogenic Actions Of Fat Mass And Obesity Associated (FTO) In Liver
por: Mizuno, Tooru, et al.
Publicado: (2019)

MON-613 The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane
por: Rizk, Nasser M, et al.
Publicado: (2020)

Dipeptidyl peptidase-4 (DPP-4; CD26)
Publicado: (2013)

THU287 Comparison Of Renal Protective Effects Between SGLT2 Inhibitors And DPP4 Inhibitors In Real-World Clinical Practice
por: Park, Hyeong-Kyu, et al.
Publicado: (2023)

SUN-690 HNF4A Mutation in Siblings with Diazoxide Responsive Congenital Hyperinsulinism
por: Erkin-Cakmak, Ayca, et al.
Publicado: (2020)

LGR4 and Its Extracellular Domain as Novel Regulators of ß-Cell Survival and Proliferation
por: Filipowska, Joanna K, et al.
Publicado: (2021)

OR05-4 Androgen Induced Metabolic Dysfunction in Female Mice is Prevented by Deletion of Liver Androgen Receptor
por: Wu, Sheng, et al.
Publicado: (2019)

OR28-4 Spontaneous Autoimmune Diabetes in Humanized Mice Carrying Human Type 1 Diabetes Susceptibility
por: Imam, Shahnawaz, et al.
Publicado: (2019)

SUN-121 Vitamin D Repletion and Sitagliptin Administration is Associated with an Increase in Serum C-Peptide and a Decrease in GAD-65 Antibody and Hemoglobin A1c in a Patient with Latent Autoimmune Diabetes of Adults
por: Fox, Nicholette, et al.
Publicado: (2019)

MON-155 A Patient with Acquired Generalized Lipodystrophy (AGL, Lawrence Syndrome) in Association with CTLA-4 Haploinsufficiency
por: Ozer, Muhammet, et al.
Publicado: (2019)

SAT-162 Hepatocyte Nuclear Factor-4α (HNF44α) as a Target to Treat DM
por: Jorge dos Santos, Gustavo, et al.
Publicado: (2019)

SUN-LB119 Role of HNF4a Isoforms in the Carbohydrate/Lipid Switch in the Liver and Responsiveness to AMPK
por: Radi, Sarah, et al.
Publicado: (2020)

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
por: Molitch, Mark, et al.
Publicado: (2019)

MON-646 Novel Use of GLP-1 Receptor Agonist Therapy in MODY-1 (HNF4A Mutation)
por: Broome, David Tyler, et al.
Publicado: (2020)

Response to Twin Enabled Precision Treatment for Reversing Diabetes: An Initial Analysis at 4 Weeks of the Ongoing Randomised Controlled Trial
por: Shamanna, Paramesh, et al.
Publicado: (2021)

MON-639 Melanocortin 4 Receptor Contributes to Glucose Homeostasis by Regulating Kidney Glucose Reabsorption via the Glucose Transporter GLUT2
por: de Souza Cordeiro, Leticia M, et al.
Publicado: (2020)

SUN-672 SGLT2 Inhibitor Reduces Hyperinsulinemia and Restores Pulsatile Growth Hormone Secretion in Obese MC4RKO Mice
por: Huang, Zhengxiang, et al.
Publicado: (2020)

Usefulness of the Continuous Glucose Monitoring (Freestyle Device) to Assess Glycemic Control of Diabetic Patients With and Without COVID 19 in a Hospital of Bogotá Colombia
por: Medina, Adriana, et al.
Publicado: (2021)

MON-178 Vitamin D Treatment of Patients with Type 1 Diabetes Reduces RORy, FoxP3 and CD4 Gene Expression in T Helper Cells
por: Penna-Martinez, Marissa, et al.
Publicado: (2019)

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
por: Solerte, Sebastiano Bruno, et al.
Publicado: (2020)

LBSUN306 Effects Of Glp-1 Receptor Agonism, Dpp4 Inhibition, And Hypocaloric Diet On Metabolic Parameters In Obese Pre-diabetic Individuals: A Randomized-controlled Trial
por: Mashayekhi, Mona, et al.
Publicado: (2022)

SUN-645 Cornus Officinalis Promotes IGFBP2 and Autophagy in Human 1.1B4 Pancreatic Cell Line as Revealed by Employing a Global Proteomic Approach via Mass Spectrometry
por: Tawfik, Arielle Elizabeth, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uf3l2euvver1grvqehss02gfii